Literature DB >> 32635304

Influence of Age on Partial Clinical Remission among Children with Newly Diagnosed Type 1 Diabetes.

Stefano Passanisi1, Giuseppina Salzano1, Albino Gasbarro1, Valentina Urzì Brancati1, Matilde Mondio1, Giovanni Battista Pajno1, Angela Alibrandi2, Fortunato Lombardo1.   

Abstract

Partial clinical remission (PCR) is a transitory period characterized by the residual endogenous insulin secretion following type 1 diabetes (T1D) diagnosis and introducing the insulin therapy. Scientific interest in PCR has been recently increasing, as this phase could be crucial to preserve functional beta cells after T1D onset, also taking advantage of new therapeutic opportunities. The aim of this study was to assess the frequency, duration and associated factors of PCR in children newly diagnosed with T1D. Our cohort study included 167 pediatric patients aged 13.8 ± 4.1 years. The association of clinical and laboratory factors with the occurrence and duration of PCR was evaluated via logistic regression and multivariable generalized linear model, respectively. PCR occurred in 63.5% of the examined patients. Patients who achieved the remission phase were significantly older, and they had lower daily insulin requirement compared with non-remitters. PCR was positively associated to body mass index (OR = 1.11; p = 0.032), pH value (OR 49.02; p = 0.003) and c-peptide levels (OR 12.8; p = 0.002). The average duration of PCR was 13.4 months, and older age at diagnosis was the only predictor factor. Two years after diagnosis remitter patients had lower HbA1c and daily insulin requirement.

Entities:  

Keywords:  C-peptide; GADA; early diagnosis; honeymoon; length

Year:  2020        PMID: 32635304     DOI: 10.3390/ijerph17134801

Source DB:  PubMed          Journal:  Int J Environ Res Public Health        ISSN: 1660-4601            Impact factor:   3.390


  5 in total

1.  Early Initiation of Intermittently Scanned Continuous Glucose Monitoring in a Pediatric Population With Type 1 Diabetes: A Real World Study.

Authors:  Roberto Franceschi; Vittoria Cauvin; Lorenza Stefani; Federica Berchielli; Massimo Soffiati; Evelina Maines
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-17       Impact factor: 6.055

2.  Increasing trend of type 1 diabetes incidence in the pediatric population of the Calabria region in 2019-2021.

Authors:  Stefano Passanisi; Giuseppina Salzano; Monica Aloe; Bruno Bombaci; Felice Citriniti; Fiorella De Berardinis; Rosaria De Marco; Nicola Lazzaro; Maria C Lia; Rosanna Lia; Francesco Mammì; Filomena A Stamati; Rosanna M R Toscano; Claudia Ventrici; Dario Iafusco; Fortunato Lombardo
Journal:  Ital J Pediatr       Date:  2022-05-04       Impact factor: 3.288

3.  Candidate Biomarkers for the Prediction and Monitoring of Partial Remission in Pediatric Type 1 Diabetes.

Authors:  Laia Gomez-Muñoz; David Perna-Barrull; Josep M Caroz-Armayones; Marta Murillo; Silvia Rodriguez-Fernandez; Aina Valls; Federico Vazquez; Jacobo Perez; Raquel Corripio; Luis Castaño; Joan Bel; Marta Vives-Pi
Journal:  Front Immunol       Date:  2022-02-23       Impact factor: 7.561

4.  BNT162b2 mRNA COVID-19 Vaccine Does Not Impact the Honeymoon Phase in Type 1 Diabetes: A Case Report.

Authors:  Marco Infante; Andrea Fabbri; Nathalia Padilla; Francesca Pacifici; Pasquale Di Perna; Laura Vitiello; Alessandra Feraco; Maria Giuliano; Marina Passeri; Massimiliano Caprio; Camillo Ricordi; David Della-Morte; Luigi Uccioli
Journal:  Vaccines (Basel)       Date:  2022-07-08

5.  Using Glycated Albumin and Stimulated C-Peptide to Define Partial Remission in Type 1 Diabetes.

Authors:  Mei Shi; Xiaolin Ji; Yuting Xie; Ting Zhong; Rong Tang; Li Fan; Xia Li
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-19       Impact factor: 6.055

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.